Jordan's syndrome
| Jordan's syndrome | |
|---|---|
| Other names | PPP2R5D-related intellectual disability, mental retardation, autosomal dominant 35(MRD35) |
| Specialty | Psychiatry, pediatrics, occupational medicine, neurology, ophthalmology |
| Symptoms | Mild to severe global developmental delay, seizure, macrocephaly, hypotonia, autism, dysmorphic facial features |
| Duration | Lifelong |
| Causes | Heterozygous PPP2R5D mutation |
| Diagnostic method | Molecular genetic testing |
| Differential diagnosis | Cowden syndrome, Sotos syndrome, Smith-Kingsmore syndrome, M-CM, MPPH, 9q34 deletion syndrome, 16p11.2 deletion syndrome |
| Management | Occupational therapy, physical therapy, speech therapy, applied behavior analysis |
| Frequency | 23 (2019) |
Jordan's syndrome (JS) or PPP2R5D-related intellectual disability is a rare autosomal dominant neurodevelopmental disorder caused by de novo mutations in the PPP2R5D gene. Children with JS may also have epilepsy or meet criteria for diagnosis with autism spectrum disorder. Also see Houge-Janssens Syndrome as 2R5D is a subunit of protein phosphatase type 2A (PP2A).